SYNTHESIS AND LEUKOTRIENE D4/E4 RECEPTOR ANTAGONIST ACTIVITY OF LY223468 AND LY281761, CARBA ANALOGS OF LY171883

被引:2
作者
GAPINSKI, DM
ROMAN, CR
RINKEMA, LE
FLEISCH, JH
机构
关键词
D O I
10.1111/j.1749-6632.1988.tb38585.x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
引用
收藏
页码:452 / 453
页数:2
相关论文
共 50 条
  • [31] LY171883, 1-LESS-THAN-2-HYDROXY-3-PROPYL-4-LESS-THAN-4-(1H-TETRAZOL-5-YL) BUTOXY-GREATER-THAN-PHENYL-GREATER-THAN-ETHANONE, AN ORALLY ACTIVE LEUKOTRIENE-D4 ANTAGONIST
    FLEISCH, JH
    RINKEMA, LE
    HAISCH, KD
    SWANSONBEAN, D
    GOODSON, T
    HO, PPK
    MARSHALL, WS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1985, 233 (01) : 148 - 157
  • [32] Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells
    Tong, WG
    Ding, XZ
    Hennig, R
    Witt, RC
    Standop, J
    Pour, PM
    Adrian, TE
    CLINICAL CANCER RESEARCH, 2002, 8 (10) : 3232 - 3242
  • [33] EVALUATION OF LY163443, 1-[2-HYDROXY-3-PROPYL-4-[[4-(1H-TETRAZOL-5-YLMETHYL)PHENOXY]METHYL]PHENYL]ETHANONE, AS A PHARMACOLOGICAL ANTAGONIST OF LEUKOTRIENES D4 AND E4
    FLEISCH, JH
    RINKEMA, LE
    HAISCH, KD
    MCCULLOUGH, D
    CARR, FP
    DILLARD, RD
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (01) : 70 - 77
  • [34] Comparative 5-HT4 receptor antagonist activity of LY353433 and its active hydroxylated metabolites
    Cohen, ML
    Bloomquist, W
    Calligaro, D
    Swanson, S
    DRUG DEVELOPMENT RESEARCH, 1998, 43 (04) : 193 - 199
  • [35] STRUCTURAL ANALOGS OF LY292728, A HIGHLY POTENT XANTHONE DICARBOXYLIC-ACID LEUKOTRIENE B-4 RECEPTOR ANTAGONIST - SPATIAL POSITIONING OF THE SECONDARY ACID GROUP
    SAWYER, JS
    SCHMITTLING, EA
    BACH, NJ
    BAKER, SR
    FROELICH, LL
    SAUSSY, DL
    MARDER, P
    JACKSON, WT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (17) : 2077 - 2082
  • [36] H-RAS 61ST CODON ACTIVATION IN ARCHIVAL PROLIFERATIVE HEPATIC-LESIONS ISOLATED FROM FEMALE B6C3F1 MICE EXPOSED TO THE LEUKOTRIENE D-4-ANTAGONIST, LY171883
    HELVERING, LM
    RICHARDSON, FC
    HORN, DM
    REXROAT, MA
    ENGELHARDT, JA
    RICHARDSON, K
    CARCINOGENESIS, 1994, 15 (02) : 331 - 333
  • [37] BENEFICIAL-EFFECTS OF LY203647, A NOVEL LEUKOTRIENE-C4/D4 ANTAGONIST, ON PULMONARY-FUNCTION AND MESENTERIC PERFUSION IN A PORCINE MODEL OF ENDOTOXIC-SHOCK AND ARDS
    COHN, SM
    KRUITHOFF, KL
    ROTHSCHILD, HR
    WANG, HL
    ANTONSSON, JB
    FINK, MP
    CIRCULATORY SHOCK, 1991, 33 (01) : 7 - 16
  • [38] LY223982 - A POTENT AND SELECTIVE ANTAGONIST OF LEUKOTRIENE-B4 - STRUCTURE ACTIVITY RELATIONSHIPS FOR THE INHIBITION OF LTB4 BINDING TO HUMAN-NEUTROPHILS
    GAPINSKI, DM
    MALLETT, BE
    FROELICH, LL
    BOYD, RJ
    JACKSON, WT
    FASEB JOURNAL, 1988, 2 (05) : A1110 - A1110
  • [39] SYNTHESIS OF LTB4 RECEPTOR ANTAGONIST LY293111 VIA A SIMPLE AND EFFICIENT SUZUKI CROSS-COUPLING
    MITCHELL, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 118 - ORGN
  • [40] The regulation of CD11b integrin levels on human blood leukocytes and leukotriene B4-stimulated skin by a specific leukotriene B4 receptor antagonist (LY293111)
    vanPelt, JPA
    deJong, EMGJ
    vanErp, PEJ
    Mitchell, MI
    Marder, P
    Spaethe, SM
    vanHooijdonk, CAEM
    Kuijpers, ALA
    vandeKerkhof, PCM
    BIOCHEMICAL PHARMACOLOGY, 1997, 53 (07) : 1005 - 1012